A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), ...

Researchers are launching a groundbreaking study to investigate how genetics and the Epstein-Barr virus may work together to ...

The effort to explore the genetic link between the Epstein-Barr virus and the risk of developing MS was awarded a $24,400 ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus ...

In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to help predict people's genetic risk of developing the ...

In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to help predict people’s genetic risk of developing the ...

New research explores the connections between long-COVID, chronic fatigue syndrome, and the role of senescent 'zombie' cells, ...

A groundbreaking Australian study is using DNA analysis to pinpoint a person's genetic risk of developing multiple sclerosis.

In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to ...

In recent years, doctors and scientists are increasingly studying long-lasting illnesses that begin after someone recovers ...

Stars including Justin Timberlake, Bella Hadid and more got candid about their experience with the tick-borne disease ...

The FDA has accepted for priority review the resubmitted BLA for tabelecleucel to treat patients 2 years of age and older with EBV+ PTLD who have received at least 1 prior therapy.